![Jesper Gromada](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jesper Gromada
Private Equity Investor at
Third Rock Ventures LLC
Profile
Jesper Gromada is currently a Venture Partner at Third Rock Ventures LLC since 2022.
Former positions include Associate Director at Eli Lilly & Co. from 2000 to 2006, VP - Muscle and Metabolism Therapeutic Areas at Regeneron Pharmaceuticals, Inc. from 2012 to 2018, Chief Scientific Officer at Exonics Therapeutics, Inc. from 2018 to 2019, Site Head-Vertex Genetic Therapies at Vertex Pharmaceuticals, Inc. from 2019 to 2020, and Chief Scientific Officer at Laronde, Inc. from 2020 to 2022.
Education includes a doctorate from the University of Copenhagen conferred in 1995.
Jesper Gromada active positions
| Companies | Position | Start |
|---|---|---|
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm targets companies operating in the fields of the healthcare sector. It provides financing for early stage capital requirements. It acts as a lead investor. | Private Equity Investor | 2022-08-31 |
Former positions of Jesper Gromada
| Companies | Position | End |
|---|---|---|
Laronde Inc.
 Laronde Inc. Miscellaneous Commercial ServicesCommercial Services Develops an eRNA therapeutic platform that capable diverse proteins inside body | Corporate Officer/Principal | 2022-08-31 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 2020-09-30 |
Exonics Therapeutics, Inc.
 Exonics Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for neuromuscular diseases | Corporate Officer/Principal | 2019-06-30 |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2018-09-30 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2005-12-31 |
Training of Jesper Gromada
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
72
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm targets companies operating in the fields of the healthcare sector. It provides financing for early stage capital requirements. It acts as a lead investor. | Finance |
Exonics Therapeutics, Inc.
Exonics Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for neuromuscular diseases | Health Technology |
Laronde Inc.
Laronde Inc. Miscellaneous Commercial ServicesCommercial Services Develops an eRNA therapeutic platform that capable diverse proteins inside body | Commercial Services |
- Stock Market
- Insiders
- Jesper Gromada
